Featured Articles

GW Survey Evaluates Influence of Social Media in Attracting Patients

Dermatology News

Featured Article

“A rapidly growing number of dermatologists are advocating for the value of social media to promote their practices,” said Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences and senior author on the study. “Only one other survey has been conducted on patient perception of social media. There hasn’t been enough to show us how effective social media is as a marketing tool for dermatologists.”

Read Article Now

GW Survey Evaluates Influence of Social Media in Attracting Patients

A survey from the George Washington University evaluated whether patients consider a dermatologist’s social media presence when looking for a doctor

WASHINGTON (May 7, 2020) – Patients often do not take social media into consideration when looking for a dermatologist, according to a survey from researchers at the George Washington University. The survey was published recently in the Journal of Drugs in Dermatology.

As of 2019, 79% of Americans have a social media presence on platforms such as Facebook, Twitter, and Instagram. Many dermatologists consider social media to be a useful tool for building their practices and recruiting patients. However, limited data exists about whether a provider’s social media presence is a driver in attracting new patients to their practice.

“A rapidly growing number of dermatologists are advocating for the value of social media to promote their practices,” said Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences and senior author on the study. “Only one other survey has been conducted on patient perception of social media. There hasn’t been enough to show us how effective social media is as a marketing tool for dermatologists.”

The GW research team distributed a 10-question online survey to a diverse patient population to evaluate their perceptions of social media and what aspects of a dermatologist’s site are the most helpful. Only 25% of respondents aged 18–30 years old thought social media was extremely or very important, suggesting that leaning on social media may not be the best way to grow a practice.

The results also indicated that respondents who did utilize social media for these purposes were interested in seeing patient education, viewing patient reviews, as well as dermatologists’ experience levels rather than personal information.

“While patients overall may not rely on social media to select a dermatologist nor be interested in nonmedical content, many of our respondents did express interest in educational content written by their dermatologists on social media,” Friedman said. “Practitioners should still count social media as a tool in building their practices and engaging their current patients, however, it should be one of many methods that they rely on to recruit new patients.”

The authors say that further research needs to be done to determine whether social media is an effective educational tool for dermatologists.

Read Article Now

You May Also Like

Featured ArticlesJDD in the MediaLatest NewsJDD in the News: Topical Nonsteroidals for Chronic Hand Eczema
May 30, 2026

JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema

Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
AestheticsDyspigmentationFeatured ArticlesLatest NewsEfficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study
May 29, 2026

Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study

Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…
Featured ArticlesLatest NewsOncodermatologySkin CancerLonger Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study
May 28, 2026

Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study

Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…

Leave a Reply